Clinical Trials Directory

Trials / Completed

CompletedNCT01941472

Transcutaneous pO2, Transcutaneous pCO2 and Central Venous SO2 Variations to Define Fluid Responsiveness

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Peking Union Medical College Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Fluid challenge is often carried out in critical ill patients. Its responsiveness usually requires invasive monitoring. To use non-invasive methods is very tempting. Investigators hypothesize that transcutaneous pO2,transcutaneous pCO2 and Central Venous SO2 variations provide feasible estimation on fluid responsiveness in critical ill patients.

Conditions

Interventions

TypeNameDescription
OTHERfluid challengeA bag of 500ml of normal saline or 4% gelatin (Gelofusine, B. Braun Medical (Suzhou) Company Limited, Suzhou, China) is infused within 15 minutes using a bag pressurized to 300 mmHg. All other treatments, including maintenance fluids, dose of vasoactive agents and ventilator settings, remain unchanged during the study period.

Timeline

Start date
2013-09-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2013-09-13
Last updated
2017-04-04
Results posted
2017-03-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01941472. Inclusion in this directory is not an endorsement.